戻る Agenda
Session1
Session Chair(s)
Takashi Moriya, PhD, MBA
Director, VEO Vaccines Value Evidence and Outcomes, Japan MA
GlaxoSmithKline K.K., Japan
Kei Tanaka
Founder
Therapeer, Japan
Speaker(s)
Session 1 - Presentation 1
Shinji Kubota
NTT Docomo, Inc., Japan
Manager, 5G & IoT Solution Office, Corporate Sales and Marketing Division
Session 1 - Presentation 2
Motohiro Kanayama
Astellas Pharma Inc., Japan
Business Producer, Rx+ Business Accelerator
Session 1 - Presentation 3
Hironobu Tokumasu, MD, MPH
Real World Data, Co., Ltd., Japan
Board Director / Chief Technology Officer
Session 1 - Presentation 4
Yoshiaki Uyama, PhD, RPh
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Session 1 - Presentation 5
Soyoku Nobeyama, MSc
Janssen Clinical Innovation, United States
Clinical Innovation Leader